Decreased serum levels of brain-derived neurotrophic factor in schizophrenic patients with deficit syndrome

• Published in: Neuropsychiatric disease and treatment Vol. 11; no. default; pp. 865 - 872
• Main Authors: Akyol, Esra Soydaş, Albayrak, Yakup, Beyazyüz, Murat, Aksoy, Nurkan, Kuloglu, Murat, Hashimoto, Kenji
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2015; Taylor & Francis Ltd; Dove Medical Press
• Subjects: Age; Analysis; Attention-deficit hyperactivity disorder; Brain research; Brain-derived neurotrophic factor; Care and treatment; Chronic illnesses; Complications and side effects; Drug dosages; Education; Hospitals; Mental depression; Mental disorders; Neurosciences; Neurotrophic factors; Neurotrophic functions; Original Research; Patients; Psychiatry; Psychotropic drugs; Research methodology; Risk factors; Schizophrenia; Serum; Studies; Ankara Turkey; Turkey; biomarker; psychosis; neurotrophin

Brain-derived neurotrophic factor (BDNF) is a well-established neurotrophin that plays a role in the pathophysiology of numerous psychiatric disorders. Many studies have investigated the serum BDNF levels in patients with schizophrenia. However, there are restricted data in the literature that compa...